BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26845807)

  • 1. TYPES OF ALBINISM IN THE BLACK SOUTHERN AFRICA POPULATION.
    Kromberg JG; Bothwell J; Kidson SH; Manga P; Kerr R; Jenkins T
    East Afr Med J; 2012 Jan; 89(1):20-7. PubMed ID: 26845807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.
    Manga P; Kromberg JG; Box NF; Sturm RA; Jenkins T; Ramsay M
    Am J Hum Genet; 1997 Nov; 61(5):1095-101. PubMed ID: 9345097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
    Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
    Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red or rufous albinism in southern Africa.
    Kromberg JG; Castle DJ; Zwane EM; Bothwell J; Kidson S; Bartel P; Phillips JI; Jenkins T
    Ophthalmic Paediatr Genet; 1990 Sep; 11(3):229-35. PubMed ID: 2126368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids.
    Kedda MA; Stevens G; Manga P; Viljoen C; Jenkins T; Ramsay M
    Am J Hum Genet; 1994 Jun; 54(6):1078-84. PubMed ID: 8198130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and genetics of oculocutaneous albinism and vitiligo - common pigmentation disorders in southern Africa.
    Manga P; Kerr R; Ramsay M; Kromberg JG
    S Afr Med J; 2013 Jul; 103(12 Suppl 1):984-8. PubMed ID: 24300644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: a study in black South Africans.
    Bothwell JE
    Int J Dermatol; 1997 Nov; 36(11):831-6. PubMed ID: 9427075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculocutaneous albinism.
    Grønskov K; Ek J; Brondum-Nielsen K
    Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculocutaneous albinism in a rural community of South Africa: a population genetic study.
    Lund PM; Maluleke TG; Gaigher I; Gaigher MJ
    Ann Hum Biol; 2007; 34(4):493-7. PubMed ID: 17620156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albinism: an update.
    Orlow SJ
    Semin Cutan Med Surg; 1997 Mar; 16(1):24-9. PubMed ID: 9125762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues.
    Ma EZ; Zhou AE; Hoegler KM; Khachemoune A
    Arch Dermatol Res; 2023 Mar; 315(2):107-116. PubMed ID: 35217926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
    Preising MN; Forster H; Gonser M; Lorenz B
    Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
    Ullah MI
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oculocutaneous and ocular albinism].
    Kubasch AS; Meurer M
    Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids.
    Stevens G; van Beukering J; Jenkins T; Ramsay M
    Am J Hum Genet; 1995 Mar; 56(3):586-91. PubMed ID: 7887411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.